Forte Biosciences board sets advisory vote on executive pay every three years

Forte Biosciences, Inc.

Stockholders at Sept. 19, 2023 annual meeting cast highest votes for annual say-on-pay, second highest for triennial.
Board decided to hold advisory vote on executive compensation every three years, citing longer-term focus.
Next vote on frequency of say-on-pay will occur no later than 2029.
41.3% of votes favored triennial frequency; board considered equity vesting and strategic long-term decisions.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Forte Biosciences, Inc. shareholders approved Advisory vote on the frequency of future advisory votes on the compensation of the Company's named executive officers at the 2023-09-19 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2023-09-19

Exact text from the filing

The highest number of votes was cast in favor of holding an advisory vote on the compensation of the Company’s named executive officers every year.

View on SEC.gov

Browse all shareholder votes →

Forte Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-038496

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.